Molecular Diagnostics Market 2021-2026 with Major Key Player: Abbott Laboratories, Agilent Technologies, Hologic and Qiagen & more

Molecular Diagnostics Market

Molecular diagnostic is an essential part of the clinical laboratory. Increased use of molecular diagnostics in pre-clinical development and approval of drugs for therapeutics and diagnosis purposes. In addition, partnership between pharmaceutical companies with diagnostic firms for the development of their drug test facility has made it an indispensable tool. The rising prevalence of chronic disease and the need for customized solutions have paved the way for molecular diagnostics in diseases diagnosis. These are also effective in identifying underlying molecular defects in hereditary diseases. In today’s time, it is the key element for the transformation of healthcare and leading in the field of molecular biology. Some of the innovations are next-generation sequencing, microarray technologies, liquid biopsies, early cancer detection, and point-of-care assays. As per Global Genes, around 350 million people suffer from a rare disease worldwide. 8 in 10 rare diseases are caused by a mutation in genes.

The Major Players Covered in this Report:
Abbott Laboratories, Agilent Technologies, Siemens AG, Biomérieux Sa, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Illumina, Roche Diagnostics, Hologic, and Qiagen.

The global molecular diagnostics market accounted for over USD 7.5 billion in 2017 and is expected to grow at a CAGR of 10.5% during the forecast period, 2019–2026.

Get a Sample PDF Report:
https://straitsresearch.com/report/Molecular-Diagnostics-market/request-sample

By Product & Services
Reagents & Kits, Instruments, Software & Services

By Technology
Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, Other Technologies

By Application
Infectious Diseases, Hepatitis, HIV, CT/NG, HAIS, HPV, Tuberculosis, Influenza, Other Infectious Diseases, Oncology, Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Cancers, Genetic Tests, Other Applications

By End-User
Hospital & Academic Laboratories, Reference Laboratories, Other End Users

Segmental Insights

The global molecular diagnostics market is segmented by product & service, technology, application, and end-user.

By product & service, the market is segmented into reagents and kits, instruments, and software & services. The reagents and kits segment is expected to grow at the fastest CAGR. The growth can be attributed to the availability of a variety of reagents & kits and the growing usage of reagents and kits in diverse therapeutic areas such as infectious diseases and oncology.

Based on technology, the global molecular diagnostics market is segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to hold the largest share due to the increasing usage of PCR in genomics and the development of automated PCR instruments.

Regional Analysis For Molecular Diagnostics Market:

North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Molecular Diagnostics are as follows:

History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2021 to 2026

Why buy this report right now?

Historical inferences, findings & analysis of the market from 2016 to 2018
Projections and performance forecast analysis for the future from 2019 to 2026
Production and consumption point of view (POV) analysis
Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

For More Details On this Report:
https://straitsresearch.com/report/Molecular-Diagnostics-market

Contact Us:

Company Name: Straits Research
Email: sales@straitsresearch.com
Phone:
+1 646 480 7505 (U.S.)
+91 8087085354 (India)
+44 208 068 9665 (U.K.)

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

This release was published on openPR.